Annals of Internal Medicine · 1982 · 262 citations · 12 references
Veterinary MedicineInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyImmunizationVaccinologyAdverse Events Following ImmunizationBacterial InfectionsVaccinationVaccine EfficacyVaccine SafetyVaccine-preventable DiseasesBacterial Meningitis TreatmentInfection Risk FactorsPneumococcal DiseasePneumococcal MeningitisPolysaccharide VaccinesVaccine Preventable InfectionsVaccine Recommendation Systems
The risk of pneumococcal infection differs in different age ranges; the risk and the severity of the infection increases in persons with certain chronic diseases. Penicillin remains the best antimicrobial agent for treatment. The recently developed pneumococcal polysaccharide vaccine represents 14 serotypes responsible for a large majority of pneumococcal infections in the United States. The efficacy of the vaccine has been demonstrated in a number of trials. This vaccine recommendation statement indicates the persons most likely to benefit from vaccination and reviews the adverse effects likely to occur and the precautions to be taken in administering the vaccine.
12
IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE
Ian Riley, Matthew Andrews, Rudolph G. Howard et al. · The Lancet · 1977 · 184 citations